PERRINE SUSAN P has a total of 18 patent applications. Its first patent ever was published in 1989. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, measurement and organic fine chemistry are POLA PHARMA INC, FALLER DOUGLAS V and FELICITEX THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | Canada | 2 | |
#4 | Egypt | 1 | |
#5 | Israel | 1 | |
#6 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Perrine Susan P | 17 |
#2 | Faller Douglas V | 6 |
#3 | White Brian F | 4 |
#4 | Albers Norbert | 3 |
#5 | Stamatoyannopoulos George | 1 |
#6 | Bohacek Regine | 1 |
#7 | Berenson Ronald J | 1 |
Publication | Filing date | Title |
---|---|---|
WO2007133653A2 | Methods for treating blood disorders | |
US6403647B1 | Pulsed administration of compositions for the treatment of blood disorders | |
US6231880B1 | Compositions and administration of compositions for the treatment of blood disorders | |
EP0969869A2 | Compositions comprising an inducing agent and an anti-viral agent for the treatment of blood, viral and cellular disorders | |
EG19413A | Method for augmenting fetal hemoglobin by treatment with activin and/or inhibin |